Björn Schniedewind
- Molecular Biology
- Transplantation top 5%
- Pediatrics, Perinatology and Child Health
- Pharmacology
- Immunology
- Co-authors
- Uwe ChristiansJeffrey L. GalinkinKeith L. HoffmanJost KlawitterTouraj ShokatiAlexander A. VinksRachel R. TaylorWenzel Schöning
- Topics
- Renal Transplantation Outcomes and Treatments (9 papers)HIV/AIDS drug development and treatment (5 papers)Pharmacological Effects and Toxicity Studies (3 papers)
- Partner nations
- United StatesGermanyThailand
In The Last Decade
Björn Schniedewind
23 papers receiving 374 citations
Peers
Comparison fields: 5 of 87
- Molecular Biology 97
- Transplantation 96
- Pediatrics, Perinatology and Child Health 66
- Pharmacology 59
- Immunology 56
Countries citing papers authored by Björn Schniedewind
This map shows the geographic impact of Björn Schniedewind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Björn Schniedewind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Björn Schniedewind more than expected).
Fields of papers citing papers by Björn Schniedewind
This network shows the impact of papers produced by Björn Schniedewind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Björn Schniedewind. The network helps show where Björn Schniedewind may publish in the future.
Co-authorship network of co-authors of Björn Schniedewind
This figure shows the co-authorship network connecting the top 25 collaborators of Björn Schniedewind. A scholar is included among the top collaborators of Björn Schniedewind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Björn Schniedewind. Björn Schniedewind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 19 | |
| 7 | 16 | |
| 8 | 24 | |
| 9 | 27 | |
| 10 | 24 | |
| 11 | 12 | |
| 12 | 3 | |
| 13 | 11 | |
| 14 | 40 | |
| 15 | 19 | |
| 16 | 16 | |
| 17 | 39 | |
| 18 | 37 | |
| 19 | 19 | |
| 20 | 36 |
About Björn Schniedewind
Björn Schniedewind is a scholar working on Transplantation, Anesthesiology and Pain Medicine and Pediatrics, Perinatology and Child Health, having authored 23 papers that have together received 381 indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (9 papers), HIV/AIDS drug development and treatment (5 papers) and Pharmacological Effects and Toxicity Studies (3 papers). The work is most often cited by research in Transplantation (96 citations), Toxicology (18 citations) and Pharmacology (59 citations). Björn Schniedewind has collaborated with scholars based in United States, Germany and Thailand. Frequent co-authors include Uwe Christians, Jeffrey L. Galinkin, Keith L. Hoffman, Jost Klawitter, Touraj Shokati, Alexander A. Vinks, Rachel R. Taylor, Wenzel Schöning, Jelena Klawitter and Meghan Cromie. Their work appears in journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Journal of Chromatography A.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.